<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: Resistant <z:chebi fb="99" ids="28017">starch</z:chebi> represents a diverse range of indigestible <z:chebi fb="99" ids="28017">starch</z:chebi>-based dietary carbohydrates </plain></SENT>
<SENT sid="1" pm="."><plain>Resistant <z:chebi fb="99" ids="28017">starch</z:chebi> has been investigated in the past for its effects on bowel health (pH, epithelial thickness, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells); reduction in postprandial glycemia; <z:mp ids='MP_0002891'>increased insulin sensitivity</z:mp>; and effects on the gut microbiome </plain></SENT>
<SENT sid="2" pm="."><plain>This review highlights advances as resistant <z:chebi fb="99" ids="28017">starch</z:chebi> gains clinical relevance as a potential treatment/preventive tool for diseases such as <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RECENT FINDINGS: Recent articles have evaluated the comparative physiological effects of different types of resistant <z:chebi fb="99" ids="28017">starch</z:chebi> and investigated the effects of resistant <z:chebi fb="99" ids="28017">starch</z:chebi> on blood <z:chebi fb="23" ids="18059">lipids</z:chebi>, body weight, and defining resistant <z:chebi fb="99" ids="28017">starch</z:chebi>-induced changes to the micriobiome that may be important in health and disease </plain></SENT>
<SENT sid="4" pm="."><plain>The most novel and relevant recent data describe a role for resistant <z:chebi fb="99" ids="28017">starch</z:chebi> in ameliorating <z:mp ids='MP_0001845'>inflammation</z:mp>; the use of resistant <z:chebi fb="99" ids="28017">starch</z:chebi> for optimal bowel health and prevention of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>; and, further, that the systemic effects of resistant <z:chebi fb="99" ids="28017">starch</z:chebi> may be important for the treatment of other forms of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, such as <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>SUMMARY: This review describes advances in resistant <z:chebi fb="99" ids="28017">starch</z:chebi> research highlighting the gastrointestinal effects that are now being linked to systemic, whole body effects with clinical relevance </plain></SENT>
<SENT sid="6" pm="."><plain>These effects have important implications for overall health and the prevention or amelioration of various <z:hpo ids='HP_0011010'>chronic</z:hpo> diseases </plain></SENT>
</text></document>